Pandemic’s cancer backlogs receive treatment from AI innovation

From Nature, 12 October 2022: The COVID-19 pandemic has stretched health-care workforces around the world to their limits, as illness and burnout extract a toll from clinicians, nurses and staff. The need for innovations that can reduce workloads is pressing and has intensified interest in artificial intelligence (AI) and robotics as potential technologies to help Continue reading Pandemic’s cancer backlogs receive treatment from AI innovation

Artificial intelligence shakes up drug discovery

From The Scientist, 1 May 2019: Australia’s government drug safety watchdog sounded the alarm about the oral antifungal agent terbinafine in 1996. The drug, sold under the brand name Lamisil by pharma giant Novartis, had come onto the market in 1993 for the treatment of fungal skin infections and thrush. But three years later, the Continue reading Artificial intelligence shakes up drug discovery